AI assistant
Sending…
Jade Biosciences, Inc. — Director's Dealing 2021
Jul 19, 2021
33383_dirs_2021-07-19_c2b4db8e-4cc8-4429-aa03-002c1d087f82.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aerovate Therapeutics, Inc. (AVTE)
CIK: 0001798749
Period of Report: 2021-07-15
Reporting Person: Dorval Allison (Director)
More from Jade Biosciences, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17